BIIO OTC
Bionovate Technologies Corp
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +6566.7%
5Y: -94.3%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$45K
-37.3% ▼
Net Income
-$107K
+12.7% ▲
EPS (Diluted)
$-0.00
+51.0% ▲
EBITDA
-$45K
-37.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5K | $0 | $0 | $0 | $0 |
| YoY Growth | -12.0% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $4K | $0 | $0 | $0 | $0 |
| Gross Profit | $906 | $0 | $0 | $0 | $0 |
| Gross Margin | 16.8% | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $89K | $119K | $57K | $33K | $45K |
| Operating Expenses | $89K | $119K | $57K | $33K | $45K |
| Operating Income | -$88K | -$119K | -$57K | -$33K | -$45K |
| Operating Margin | -1628.9% | — | — | — | — |
| Interest Expense | $61K | $67K | $152K | $89K | $61K |
| Income Before Tax | -$341K | -$2M | -$209K | -$122K | -$107K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$323K | -$2M | -$209K | -$122K | -$107K |
| Net Margin | -6002.8% | — | — | — | — |
| EPS (Diluted) | $-1.09 | $-27.46 | $-1.34 | $-0.00 | $-0.00 |
| EBITDA | -$280K | $0 | -$290 | -$33K | -$45K |
| Shares Outstanding | 298018 | 63403 | 155798 | 25M | 45M |